Miga Health: Advancing Cardiovascular Care

Developing medical products and services for conditions that lead to heart disease

Published on


2 min

Cardiovascular disease is the leading cause of death globally, claiming an estimated 17.9 million lives each year. Unfortunately, traditional provider-based medicine fails to keep pace with evolving patient needs and health concerns. Now more than ever, there is a need for consumer-focused healthcare products and services designed to help reduce heart-related epidemics.

Alumni Ventures’ portfolio company Miga Health is responding to this need through its consumer-focused health platform that develops medical products and services for hypertension, hyperlipidemia, and other chronic conditions. Miga’s platform also covers the increasing demand for mobile healthtech — a market expected to reach $250 billion by 2026. The company’s digital platform includes at-home blood pressure monitoring delivered through a native mobile experience, telemedicine consultations, mail-order pharmacies, and lifestyle coaching.


Unhealthy diets, lack of physical activity, and consumption of alcohol and tobacco are the leading causes of hypertension. Miga Health’s platform offers a range of alternative health and wellness tech products to help improve these habits, including:

  • Digital therapies and behavioral tools
  • Fitness-related products, such as exercise equipment, health-monitoring tools, and nutrition services
  • Genomic science tools rooted in emerging research

In addition to preventative measures, a big challenge with heart health treatment is insufficient testing and underprescribing existing medications. Miga Health addresses this issue through personalized educational content, partnerships with consumers, and a platform that brings together key stakeholders (i.e., consumers, physicians, biopharma, and employers). Miga hopes to acquire, engage, and activate consumers to transact on these medical products and services by building out this consumer-grade set of product features.

What We Liked About Miga 

Experienced Founding Team: Co-Founders Jarrad Aguirre and Dre Limberopoulos bring deep healthcare expertise and entrepreneurial experience to Miga. Before founding the company, Aguirre worked as a physician, researcher, and consultant across the spectrum of health and healthcare, including at Brigham and Women’s Hospital. Jarrad was a Rhodes Scholar and was also named to Biz Journal’s 40 under 40 in Healthcare.

Dre is a software engineer and a serial entrepreneur. He founded several companies before Miga, including a digital identity startup called Everproof, used by more than 1,500 organizations in Australia.

Robust Product Model: Miga Health plans to launch with a cash pay model and progress towards a mix of cash pay and insurer coverage for their medical products and services. The company also plans to bring diagnostics, medical services, and pharmacy in-house to improve margins and improve the brand experience. 

Investor Syndicate With a Successful Track Record: Quiet Capital, Lux Capital, and Floating Point have a demonstrated track record of success in digital health. The firms’ notable investments in the space include One Medical, Auris, Oscar, and Ro. 

How We Are Involved

Green D Ventures (for the Dartmouth community) sponsored Alumni Ventures’ investment in Miga Health’s $12 million seed round led by Quiet Capital. The deal was also part of Alumni Ventures’ Healthtech Fund — a diversified healthtech and life sciences investment portfolio.

Want to learn more?
View all our available funds and secure data rooms, or schedule an intro call.

New to AV?
Sign up and access exclusive venture content.

Contact [email protected] for additional information. To see additional risk factors and investment considerations, visit av-funds.com/disclosures.